
Seneca study
@senecastudy
The official Twitter account for the SENECA Study: Staging Endometrial caNcer based on molEcular ClAssification. PI: @quique_chc Email: [email protected]
ID: 1614599465356115968
https://clinicaltrials.gov/ct2/show/NCT05707312?term=NCT05707312&draw=2&rank=1 15-01-2023 12:25:11
59 Tweet
354 Followers
772 Following


Our SENECA study has just been published! I am honoured to have led this ambitious project with more than 2000 patients from more than 60 centres all over the world! Thank you all for your collaboration! Together further! Clínica Universidad de Navarra Luis Chiva x.com/IJGConline/sta…

Clínica Universidad de Navarra Luis Chiva Check out our podcast! x.com/IJGConline/sta…

#Editorial on #SENECA study Seneca study @ bit.ly/3MA71Fm #SLNmapping #EndometrialCancer Enrique Chacón Clínica Universidad de Navarra Jennifer Müller Beryl Manning-Geist, MD Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows


📣 📣 📣 Join us #IJGCclub 📆Sept 24 ⏰11am CDT/6pm CET Enrique Chacón will be discussing about the Seneca study 👉 Staging endometrial cancer based on molecular classification Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists


📣 📣 📣 Join us #IJGCclub 📆Sept 24 ⏰11am CDT/6pm CET Enrique Chacón will be discussing about the Seneca study 👉 Staging endometrial cancer based on molecular classification 💻 bit.ly/47E3jEn Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS


See you in 30 mins 🕒 It's almost time! Join us in 30 mins for our #IJGCclub! 📚✨ Don't miss out on this exciting discussion with Enrique Chacón on the Seneca study 👉 Staging endometrial cancer based on molecular classification See you soon! Zoom link 💻


Incredible discussion today!🤩 Huge thanks to the Seneca study team and Enrique Chacón for the amazing results, and to our attendees and societies ESGO and IGCS A fantastic first #IJGCclub for our IJGC Fellows! See you in October! 🎉 Pedro T Ramirez Arthur_HC_Hsu



The Spanish Congress of Gynecology Oncology has just concluded. We were able to present two sub-analyses of the SENECA study and the validation our predictive index for complete cytoreduction in advanced ovarian cancer… A lot of science and friends… we keep going! Onco.SEGO2024


Vuelve la VI Edición del Curso de Cirugía Ginecológica Avanzada! Dos jornadas intensivas con práctica en modelo “cadáver en fresco y porcino", en un entorno único,Clínica Universidad de Navarra🏥 Aprende de grandes expertos Luis Chiva🔝 y perfecciona tus habilidades quirúrgicas🔪 Inscríbete ya!🎯

Results of the SUROVA study are coming out in less than 2 hours!!!😱😱😱 We look forward to seeing you in Session Hall 1 to share with you new evidence in advanced ovarian cancer surgery! 🔪🔪🔪 Stay tuned!!! 🎯🎯🎯 #esgo2025 Luis Chiva Clínica Universidad de Navarra


2139 patients with EC. Bilateral detection rate 82.3%. More than 20 surgical variables analyzed. 5 Risk factors -Modifiable: 👉🏻Open approach 👉🏻Non ICG tracer 👉🏻Low volume surgeon (<20sln/year) -Non modifiable: ❌High grade and >50%myo inv #surgery #endometrialcancer SoMe4Surgery




Sentinel #SENECA risk factors for unsuccessful bi-lateral SLN mapping in #endometrialcancer Felix Boria 📌 bit.ly/3SLqR3C Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc Helena Obermair


🚨 New episode of #IJGCconversations is out! Félix Boria Felix Boria dives into the key risk factor for unsuccessful #SLN mapping. Tune in to stay updated on the latest in #GynOnc 🎧 bit.ly/4jkbb24 Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS